Graciano, Antonia F.
HRN: 21-27-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2022
CEFTRIAXONE 1G (VIAL)
04/21/2022
04/28/2022
IV
2g
OD
Pus Cells 25-30
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes